FDA Panel Splits On Removal Of Weight-Loss Drug Meridia From US Market – Wall Street Journal

WASHINGTON (Dow Jones)–A Food and Drug Administration panel was split Wednesday on whether to recommend Abbott Laboratories’ (ABT) weight-loss drug Meridia be removed from the U.S. market due to concerns that the drug raises the risks of heart problems …

Read the original post on weight loss – Bing News